Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 mice  by Elamin, Ashraf et al.
Journal of Proteomics 145 (2016) 237–245
Contents lists available at ScienceDirect
Journal of Proteomics
j ourna l homepage: www.e lsev ie r .com/ locate / jp rotQuantitative proteomics analysis using 2D-PAGE to investigate the
effects of cigarette smoke and aerosol of a prototypic modiﬁed risk
tobacco product on the lung proteome in C57BL/6miceAshraf Elamin a,1, Bjoern Titz a,1, Sophie Dijon a,1, Celine Merg a, Marcel Geertz a,d, Thomas Schneider a,
Florian Martin a, Walter K. Schlage c, Stefan Frentzel a, Fabio Talamo a, Blaine Phillips b, Emilija Veljkovic b,
Nikolai V. Ivanov a, Patrick Vanscheeuwijck a, Manuel C. Peitsch a, Julia Hoeng a,⁎
a Philip Morris Research and Development, Philip Morris Products SA (part of Philip Morris International group of companies), Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland
b Philip Morris International Research Laboratories (part of Philip Morris International group of companies), 50 Science Park Road, 117406, Singapore
c Biology Consultant, Max-Baermann-Str. 21, 51429, Bergisch Gladbach, Germany
d Bayer Technology Services GmbH, 51368 Leverkusen, Germany⁎ Corresponding author at: Philip Morris International R
2000 Neuchâtel, Switzerland.
E-mail address: Julia.hoeng@pmi.com (J. Hoeng).
1 AE, BT, and SD contributed equally to this manuscript
http://dx.doi.org/10.1016/j.jprot.2016.05.037
1874-3919/© 2016 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 30 March 2016
Received in revised form 27 May 2016
Accepted 28 May 2016
Available online 5 June 2016Smoking is associated with several serious diseases, such as lung cancer and chronic obstructive pulmonary dis-
ease (COPD).Within our systems toxicology framework,we are assessingwhether potential modiﬁed risk tobac-
co products (MRTP) can reduce smoking-related health risks compared to conventional cigarettes. In this article,
we evaluated to what extent 2D-PAGE/MALDI MS/MS (2D-PAGE) can complement the iTRAQ LC-MS/MS results
from a previously reported mouse inhalation study, in which we assessed a prototypic MRTP (pMRTP). Selected
differentially expressed proteins identiﬁed by both LC-MS/MS and 2D-PAGE approaches were further veriﬁed
using reverse-phase proteinmicroarrays. LC-MS/MS captured the effects of cigarette smoke (CS) on the lung pro-
teome more comprehensively than 2D-PAGE. However, an integrated analysis of both proteomics data sets
showed that 2D-PAGE data complement the LC-MS/MS results by supporting the overall trend of lower effects
of pMRTP aerosol than CS on the lung proteome. Biological effects of CS exposure supported by bothmethods in-
cluded increases in immune-related, surfactantmetabolism, proteasome, and actin cytoskeleton protein clusters.
Overall, while 2D-PAGE has its value, especially as a complementary method for the analysis of effects on intact
proteins, LC-MS/MS approaches will likely be the method of choice for proteome analysis in systems toxicology
investigations.
Signiﬁcance: Quantitative proteomics is anticipated to play a growing role within systems toxicology assessment
frameworks in the future. To further understand howdifferent proteomics technologies can contribute to toxicity
assessment, we conducted a quantitative proteomics analysis using 2D-PAGE and isobaric tag-based LC-MS/MS
approaches and compared the results produced from the 2 approaches. Using a prototypic modiﬁed risk tobacco
product (pMRTP) as our test item, we show compared with cigarette smoke, how 2D-PAGE results can comple-
ment and support LC-MS/MS data, demonstrating themuch lower effects of pMRTP aerosol than cigarette smoke
on the mouse lung proteome. The combined analysis of 2D-PAGE and LC-MS/MS data identiﬁed an effect of cig-
arette smoke on the proteasome and actin cytoskeleton in the lung.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Systems toxicology






Smoking is the cause of several serious diseases such as lung cancer,
cardiovascular disease and chronic obstructive pulmonary diseases.
Smoking cessation is the best option for smokers to reduce the risk for&D, Philip Morris Products S.A.,
.
. This is an open access article underadverse health outcomes. For smokers who otherwise would not quit,
switching to less hazardous products provides an alternative way to re-
duce the harm from smoking-related diseases. In this context, a modi-
ﬁed risk tobacco product (MRTP) is deﬁned as “any tobacco product
that is sold or distributed for use to reduce harm or the risk of tobac-
co-related disease associated with commercially marketed tobacco
products” [1]. Combustion of organic tobacco compounds at elevated
temperatures has been identiﬁed as the major source of the harmful
or potentially harmful constituents (HPHCs) of cigarette smoke, as
most HPHCs are produced through pyrolysis and pyrosynthesis [2–6].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
238 A. Elamin et al. / Journal of Proteomics 145 (2016) 237–245This fact forms the basis for the development of MRTPs that rely on the
heat-not-burn concept and prevent combustion processes by applying
lower, well-controlled temperatures for the generation of an aerosol
with a signiﬁcantly reduced content of HPHCs compared with cigarette
smoke (e.g., [2,7,8]). For one of the prototypic MRTP (pMRTP), devel-
oped by Philip Morris International and tested in two previously con-
ducted in vivo studies, this is achieved with a carbon tip attached to a
column of tobacco ﬁller; the tip serves as a heat source to generate an
aerosol [8,9].
To assess the biological effects of potential MRTPs, we are
conducting studies engaging a systems toxicology approach that com-
bines evaluation of classical toxicological endpoints with extensive mo-
lecularmeasurements and computational analysis approaches [10]. The
aim is to provide a deepermechanistic understanding of the induced bi-
ological effects, toward a more robust and sensitive detection of these
effects. To achieve this, we routinely combine different “omics” mea-
surement techniques to capture how the transcriptome, proteome and
lipidome of various rodent's organs including lungs, a target organ for
smoke related pathologies, are affected by the exposure conditions [8,
11]. For the proteomics analyses, we have established a robust LC-MS/
MS workﬂow using isobaric tag-based quantiﬁcation (iTRAQ® or
TMT™) that allows for multiplexed analyses and supports the quantita-
tive assessment of several molecular processes in lung tissue known to
be affected by CS exposure (xenobiotic, oxidative stress, metabolic, and
immune responses) (e.g., [7,8,11–13]). However, proteomics methods
based on 2D-PAGE/Matrix Assisted Laser Desorption Ionization
(MALDI) MS/MS have been the centerpiece of toxicoproteomics for a
long time and provide a complementary way to analyze proteomes, as
they are based on the separation of intact proteins rather than cleaved
peptides (as in our LC-MS/MS workﬂow [14,15]). While a few direct
comparisons between LC-MS/MS and 2D-PAGE/MALDI MS/MS
workﬂows are available (e.g., [16]), our question was to what extent
2D-PAGE/MALDI MS/MS results can complement LC-MS/MS results in
the context of systems toxicology studies.
In this article, we compared quantitative lung proteomics results
from 2D-PAGE and iTRAQ-based LC-MS/MS analyses from a 7-month
mouse inhalation study on C57BL/6 mice, which has been previously
published, including the iTRAQ results only [8,11]. In this inhalation
study, we compared the biological effects of exposures to CS, aerosol
of a prototypic MRTP (pMRTP), switching from CS to pMRTP aerosol
and cessation. Consistent with previous reports, we found that the
iTRAQ-based workﬂow provides a larger coverage of the exposure ef-
fects than 2D-PAGE. Nevertheless, the 2D-PAGE results complement
the iTRAQ results by reconﬁrming the general trends and supporting
the identiﬁcation of speciﬁc protein clusters affected by CS exposure.
2. Materials and methods
2.1. Experimental design
The study included ﬁve groups of mice, exposed as follows: 1. sham
(exposed to ﬁltered fresh air); 2. CS (exposed to mainstream smoke
from 3R4F, a reference cigarette from the University of Kentucky); 3.
pMRTP (exposed to aerosol from the prototypicMRTP); 4. smoking ces-
sation (CS followed by smoking cessation); and 5. switching to pMRTP
(CS followed by pMRTP). C57BL/6 mice were exposed as indicated for
up to 7months. Tomodel the effects of smoking cessation and switching
to the pMRTP, groups of micewere ﬁrst exposed to CS for 2months and
exposure was then changed to ﬁltered air (cessation) or pMRTP
(switching) for an additional 5 months. The 2-month time point for
switching/cessation was chosen based on the results of a previously
conducted inhalation study on C57BL/6 mice, which had indicated
that lung inﬂammation, emphysema, and changed pulmonary function
were already apparent after 2months of exposure to 3R4F [17]. Lung tis-
sue samples for proteomics analysis were collected after 1, 3, 5, and
7 months of exposure – an additional 4 month time point was analyzedby a reverse phase protein array (RPPA). Each C57BL/6 group at each
sample collection point included six mice (six biological replicates) for
the 2D-PAGE analysis and ten mice (ten biological replicates) for the
RPPA analysis.
For additional details on the endpoints of this 7-month C57BL/6
mouse inhalation study, the reader is referred to Phillips et al. [8] and
[18]. The iTRAQ® analysis was performed in six biological replicates.
For more details on the iTRAQ® analysis see Titz et al. [11] and the Sup-
plementary Text.
2.2. Animals
All procedures involving animals were approved by an Institutional
Animal Care and Use Committee, in compliancewith the National Advi-
sory Committee for Laboratory Animal Research (NACLAR) Guidelines
on the Care and Use of Animals for Scientiﬁc Purposes. In accordance
with the “3Rs” principles of animal research (replacement, reduction
and reﬁnement), we used the minimum number of animals needed to
obtain valid results and the least invasive procedures to minimize pain
and distress. Our laboratory technicians and veterinary specialists are
trained in the latest techniques to most effectively and humanely man-
age and care for animals.
Female C57BL/6mice bred under speciﬁc pathogen-free conditions
were obtained from Charles River, Wilmington, MA, USA. The mice
were 8–10 weeks old at the start of exposure. See Ansari et al. [18] for
more details and for an overview of the number of animals assigned
to the different endpoints of the study.
2.3. Reference cigarettes and pMRTP
3R4F cigarettes were purchased from the University of Kentucky
(Lexington, KY, USA; http://www.ca.uky.edu/refcig). pMRTP (Philip
Morris Products S.A., Neuchâtel, Switzerland) has a carbon tip attached
to a tobacco plug that serves as a fast-lighting heat source to generate an
aerosol. With this, the temperature applied to the tobacco plug is below
the combustion temperature. This technology, by avoiding tobacco
combustion, reduces formation of HPHCs [8].
2.4. Smoke generation and animal exposure
Mainstream CS from 3R4F cigarettes was generated on a 30-port ro-
tary smokingmachine (type PMRL-G, SM2000) as described previously
[8,9]. pMRTP aerosol was generated in modiﬁed SM2000 machines.
3R4F cigarettes and pMRTP sticks were smoked according to the Health
Canada Intensive Smoking Protocol based on ISO standard 3308 (re-
vised in 2000), with the exception of the puff volume (55 mL) and
puff frequency (one puff every 30 s), as described previously [8]. Several
additional minor deviations from ISO standard 3308 were necessary for
technical reasons [8]. Aerosols were diluted with conditioned fresh air
to achieve the target concentrations.
The C57BL/6mice were whole body-exposed to diluted mainstream
smoke from 3R4F cigarettes (750 mg TPM/m3, equivalent to 34.4 mg
nicotine/m3), pMRTP aerosol (nicotine-matched to 3R4F, 34.4 mg/m3),
or ﬁltered air, for 4 h per day, 5 days per week, for up to 7 months,
with intermittent daily exposure to fresh ﬁltered air for 30 min after
the ﬁrst hour of smoke exposure and for 60 min after the second and
third hours of exposure. Mice exposed only to fresh air served as the
control (sham) group. Reproducibility of smoke generationwas ensured
by periodic analysis of the test atmosphere during the study, and reli-
able exposure of the mice was veriﬁed by a number of biomarkers
(see [8] for details).
2.5. 2D-PAGE
The TissueLyser II (Qiagen, Hilden, Germany) bead-mill disruption
system was used for protein extraction from cryo-sliced right lung
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performed according to the manufacturer's instructions, using one 5-
mm steel bead (Qiagen) and 1 mL of lysis buffer ReadyPrep 2D Protein
Extraction Kit (Total) (7 M urea, 2 M thiourea, 1% (w/v)
Amidosulfobetaine-14, 40 mM Tris base, and 0.001% Bromophenol
Blue, Biorad) completedwith (v/v) 1% Tributylphosphine, (v/v) 10% Eth-
anol HPLC Grade (Sigma Aldrich), (v/v) 0.5% Protease inhibitor (prote-
ase inhibitor, GE Healthcare) and (1tab/10 mL) Phosphatase inhibitor
(PhosSTOP, Roche). After a centrifugation for 10 min at 16 000 ×g, the
supernatant was collected in a fresh tube then underwent an acetone-
precipitation. The precipitated sample was resuspended in ReadyPrep
2D Starter kit rehydration/sample buffer (8 M urea, 2% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate, 50mM di-
thiothreitol, 0.2% Bio-lyte ampholytes pH gradient buffer pH 3–10, and
bromophenol blue; BioRad). The protein concentrationwas determined
using the modiﬁed Bradford protein assay (BioRad).
Isoelectric focusing was performed using 250 μg of proteins on 11-
cm immobilized pH gradient strips (Readystrip IPG strip 3–10NL,
BioRad)with a pH 3–10 nonlinear gradient, on an Ettan IPGphor System
(GE Healthcare, Little Chalfont, UK). The proteins bound to the strips
were reduced and alkylated before separation in a second dimension
using a Criterion XT Bis-Tris Gel, 12%, 13.3 × 8.7 cm (W × L) (BioRad).
For image analysis, the gels were visualized with SYPRO Ruby staining
(Invitrogen, Carlsbad, CA, USA). After scanning of the gels, spot-intensi-
ty calibration, spot detection, background abstraction, and matching of
2D-PAGE were performed on the digitized images using SameSpots
software (Nonlinear, Newcastle upon Tyne, UK). The comparative anal-
yses of all gels was based only on the spots detected at month 7 so as to
apply the same set throughout the four time points. For the detection of
differentially expressed proteins (exposure vs. sham), the values were
log transformed, a linear model was ﬁt for each exposure condition
and its respective sham group (from the same time point), and p-values
from a moderated t-statistics were calculated with the empirical Bayes
approach [19]. The Benjamini-Hochberg false discovery rate (fdr)meth-
odwas then used to correct for multiple testing effects. Proteinswith an
fdr-adjusted p-value b0.05 were considered as differentially expressed.
For identiﬁcation, protein spots were excised from the gels, followed
bywashing and in-gel digestion with 20 ng of Trypsin Gold, Mass Spec-
trometry Grade (Promega, Madison, WI, USA) using an ETTAN digester
robot (GE Healthcare). The extracted tryptic peptides were mixed with
cyano-4-hydroxycinnamic acid matrix (Bruker, Bremen, Germany) and
deposited on a MALDI target plate to be analyzed. Peptide mass ﬁnger-
print data and mass spectra were acquired by MALDI time-of-ﬂight
mass spectrometry (UltraFleXtreme MALDI-TOF/TOF-MS; Bruker) and
identiﬁedwith theMASCOT search programand the SwissProt database
(Taxonomy: Mus musculus, Enzyme: Trypsin, Missed cleavages ≤2,
Global modiﬁcations: Oxidation (M), Variable modiﬁcations: Carba-
midomethylation (C), MS tolerance: 100 ppm, MS/MS Tolerance:
0.7 Da).
2.6. Reverse-phase protein array (RPPA) analysis
The TissueLyser II (Qiagen, Hilden, Germany) bead-mill disruption
system was used for protein extraction from cryo-sliced right lung tis-
sue samples of ten mice. Protein extraction was performed according
to themanufacturer's instructions, using one 5-mm steel bead (Qiagen)
and 400 μL CLB1 extraction buffer (Bayer Technology Services GmbH,
Leverkusen, Germany). After extraction, the samples were centrifuged
in a microcentrifuge for 10 min at 11,000 ×g, and the supernatant was
transferred into fresh tubes for further analysis. Protein concentration
in collected supernatants was quantiﬁed using an EZQ test (Life Tech-
nologies, Carlsbad, CA, USA). Protein extracts were stored at −80 °C
until further use.
Analysis of protein extracts by Zeptosens® RPPA technology was
performed as previously described [20]. Protein extracts were diluted
with CLB1 buffer to a ﬁnal spotting concentration of 0.2 μg/μL. Dilutedextracts were printed at four serial dilutions (1.6-fold) onto Zeptosens®
hydrophobic chips (Bayer Technology Services GmbH) using a microar-
ray printer (NanoPlotter 2.1, GeSiM, Grosserkmannsdorf, Germany).
Each sample was processed in technical duplicate with independent di-
lutions on separate arrays, i.e., eight spots per sample with four spots
per array. Following array printing, arrays were blocked, washed, and
dried according to the manufacturer's speciﬁcations and stored at 4 °C
in the dark until use.
For measurement of protein signals, arrays were incubated over-
night at room temperature in primary antibodies at dilutions of
1:500 in CAB1 assay buffer (Bayer Technology Services GmbH). The
following primary antibodies were used: Chi3l1 (#sc-30861, Santa
Cruz Biotechnology, Dallas, TX, USA), Actb (#4970, Cell Signaling
Technology, Danvers, MA, USA), Ctsd (#TA301315, Origene, Rock-
ville, MD, USA), Vim (#LS-B4669, LSBio, Seattle, WA, USA), Asah1
(#ARP57760_P050, Aviva Systems Biology, San Diego, CA, USA),
Capg (#sc-33084, Santa Cruz Biotechnology), Psma5 (#TA310789,
Origene), Capzb (#AB6017, Merck Millipore, Darmstadt, Germany),
and Sftpa (#sc-13977, Santa Cruz Biotechnology). Following wash-
ing, arrays were incubated for 2 h with either Alexa647- (Life Tech-
nologies) or Dylight650- (Bio-Rad AbD Serotec GmbH, Puchheim,
Germany) labeled anti-species secondary antibodies at dilutions of
1:500. After subsequent washing, stained arrays were imaged using
an array scanner (ZeptoREADER, Bayer Technology Services GmbH)
according to the manufacturer's recommendations. For correction
for secondary antibody staining, arrays were assayed in the absence
of primary antibodies. For measurement of spotted protein amounts,
one blank chip (i.e., without antibody incubation) was stained with
SYPRO® Ruby. Scanned images were analyzed using ZeptoVIEW 3.1
software (Bayer Technology Services GmbH). Normalized ﬂuores-
cence intensity (NFI) for each sample and protein target were calcu-
lated as reference ﬂuorescence intensities of primary antibody
stained arrays (RFIprimary) corrected for secondary antibody
staining (RFIsecondary), as well as relative spotted protein concen-
tration (RFIprotein), determined by (RFIprimary − RFIsecondary)/
RFIprotein, using the ZeptoVIEW 3.1 software. NFI values were
used for subsequent analysis. Statistics was based on t-tests of log-
transformed data; only comparisons with at least three not missing
values per group considered. The Benjamini-Hochberg false discov-
ery rate (fdr) method was then used to correct for multiple testing
effects. Proteins with an fdr-adjusted p-value b0.05 were considered
as differentially expressed.
2.7. Additional data analysis methods
For the comparison of 2D-PAGE and iTRAQ data, gene set analysis
(GSA) was conducted with the Piano package in the R statistical en-
vironment [21]. Gene sets were deﬁned based on the differentially
expressed proteins from the 2D-PAGE analysis. GSA of these sets
was performed for each comparison of the iTRAQ data, fold-change
was used as the gene/protein statistic, the mean of the fold-changes
as the set statistic, and gene/protein permutation with false-discov-
ery rate correction of the obtained p-values to estimate signiﬁcance.
Functional associations among proteins were obtained from the
STRING database [22]. Functional clusters were identiﬁed using an
information-theoretic algorithm [23] and manually annotated guid-
ed by ToppGene [24].
2.8. Data availability
The 2D-PAGE data are available from ﬁgshare (see [18]). The iTRAQ
mass spectrometry proteomics data are available from the
ProteomeXchange Consortium via the PRIDE partner repository
(http://www.ebi.ac.uk/pride/archive/) [25]. The database identiﬁer is
PXD001369.
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3.1. Design of 7-month mouse exposure study with multiple proteomics
endpoints
The lung proteomics results presented here are part of a larger sys-
tems toxicology assessment study of pMRTP, a prototypic MRTP [8,18],
and we have already published an integrative analysis of the iTRAQ-
based quantitative lung proteomics data [11]. The current manuscript
focuses on the results from 2D-PAGE analysis of the lung proteome,
comparison and integration with the iTRAQ data, and further veriﬁca-
tion of selected differentially expressed proteins using RPPA.
Brieﬂy, C57BL/6micewere exposed for up to 7months to ﬁltered air
(sham), CS from the 3R4F reference cigarette (3R4F), or aerosol from
the pMRTP (Fig. 1A). In addition, cessation and switching groups were
ﬁrst exposed to 3R4F CS for 2 months and subsequently to fresh air
and pMRTP aerosol, respectively. Importantly, the pMRTP aerosol expo-
surewasmatched in nicotine concentration to the3R4F CS exposure. Ef-
fective and robust exposure conditions including comparable nicotine
uptake were conﬁrmed and the results are summarized in Phillips et
al. [8].
3.2. 2D-PAGE captures exposure response of the lung proteome
Tomeasure the response of the lung proteome, tissue samples taken
at the end of months 1, 3, 5, and 7 were analyzed. These samples were
analyzed by 2D-PAGE using separation by isoelectric focusing on 11-
cm immobilized pH gradient strips (pH 3–10, nonlinear gradient) and,
subsequently, by SDS-PAGE. Protein spots were stained with SYPRO
Ruby, quantiﬁed, then identiﬁed (Fig. 1B, C).
First, we compared the amplitude (fold-changes) and statistical sig-
niﬁcance of the effects (Fig. 2A, Supplementary Table 1). 3R4F CS clearly
induced changes in the lung proteome that appeared to increase over
time – with the highest number of protein spots identiﬁed above the
signiﬁcance threshold (fdr-adjusted p-value b0.05) for month 7. In con-
trast, pMRTP aerosol exposure did not result in statistically signiﬁcant
effects on the lung proteome compared with the respective sham
groups as measured by 2D-PAGE. Differential protein expressions inFig. 1.Design of 7-month CS exposure study and 2D-PAGEworkﬂow. (A) Schematic of the study
prototypicmodiﬁed risk product (pMRTP) or fresh air (sham). Somemicewere exposed to CS fo
tissue samples for 2D-PAGE, iTRAQ, and RPPA were collected at the indicated time points. (B)the cessation and switching groups appeared to return quickly to
sham group levels. The numbers of proteins (i.e., protein spots) with
statistically signiﬁcant differential abundance (fdr-adjusted p-value
b0.05) are summarized in Fig. 2B. Note that for some protein spots
with differential abundance, the proteins could not be identiﬁed.
In total, we were able to identify 20 protein spots (mapped to 17
proteins) with differential abundance, of which 17 demonstrated up-
regulation compared with the sham group (Fig. 2C). Overall, these pro-
teins showed similar response proﬁles with the largest effect after
7 months of 3R4F exposure, low to absent effects after pMRTP aerosol
exposure, and a tendency to still be affected in samples taken at the
ﬁrst cessation or switching time point, i.e., 1 month after switching/ces-
sation. Examples of the 2D-PAGE spot intensities for proteins Ctsd and
Fabp5 are shown in Fig. 2D and E.
3.3. Comparison of 2D-PAGE and iTRAQ lung proteome response proﬁles
Wehave already reported on the lung proteome results of this study
obtainedwith the iTRAQ isobaric labeling approach [8,11]. Using iTRAQ,
4347 proteins (protein groups) were identiﬁed. However, of these only
about 2000 proteins were consistently identiﬁed in at least two-thirds
of the replicates and used for quantitative assessment (Fig. 3A). Using
the 2D-PAGE approach, we identiﬁed more than 1500 protein spots
consistently across all samples, because we used the same quantiﬁca-
tion mask for all gels (see Section 2).
While, overall, the 2D-PAGE approach conﬁrmed the differences in
the lung proteome response between 3R4F CS exposure, pMRTP aerosol
exposure, switching, and cessation, a lower number of proteins were
identiﬁed as differentially abundant as compared to iTRAQ experiments
– e.g., for 7 months of 3R4F vs. sham exposure ~700 differentially
expressed proteins (DEPs) were identiﬁed by iTRAQ and ~50 DEPs
were identiﬁed by 2D-PAGE (Fig. 3A). The differenceswere likely attrib-
uted to the higher variance in 2D-PAGE and lower separation power as
compared to the iTRAQ data (Supplementary Fig. 1).
To assess the similarity between the proteome response detected by
2D-PAGE and iTRAQ, we conducted a set enrichment analysis across the
two data types (Fig. 3B). With this, we tested whether the sets of up- or
down-regulated proteins identiﬁed by 2D-PAGEwere also differentiallydesign and sampling time points. C57BL/6micewere exposed to cigarette smoke (3R4F), a
r 2months and then either underwent cessation orwere switched to pMRTP aerosol. Lung
Workﬂow of 2D-PAGE experiment. (C) Representative example of a stained 2D gel.
Fig. 2. 2D-PAGE captures the lung proteome response to CS and pMRTP exposure. (A) Volcano plots showing the effect amplitude (log2 fold-change, x-axis) and signiﬁcance (−log10
adjusted p-value, y-axis) in the exposure groups compared with sham exposure. The signiﬁcance threshold of the fdr-adjusted p-value = 0.05 (1.3 in log10 space) is indicated and
signiﬁcantly up and downregulated proteins (protein spots) detected by 2D-PAGE are shown as yellow and blue dots, respectively. (B) Summary of the number of detected
differentially expressed proteins (DEPs) in total and that could be identiﬁed by MALDI-TOF. (C) Protein response heatmap for all identiﬁed proteins with signiﬁcant differential
expression by 2D-PAGE (fdr-adjusted p-value b 0.05). Each row represents a protein spot (labeled with protein name and spot number), each column represents an exposure group
vs. sham comparison. The log2 fold-change is color-coded (see color key) and the statistical signiﬁcance indicated (× = adj. p b 0.05; * = adj. p b 0.01). Note that for the basic statistics
we counted different protein spots for the same proteins separately. (D) Representative spot intensities of protein Ctsd (spot #2765) for one replicate of the 7 month time point (2D-
and 3D- representation). (E) As D, but for Fabp5 (spot #2280).
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signiﬁcantly upregulated by 2D-PAGE showed a signiﬁcant association
speciﬁcally with the upregulated proteins in the iTRAQ data set upon
3R4F exposure, as well as with those identiﬁed at the ﬁrst time points
after cessation/switching.
For comparison of individual protein responses, we focused on the
7-month 3R4F vs. sham exposure data, which showed the largest num-
ber of differentially expressed proteins by 2D-PAGE (Fig. 3C). For this,
only proteinswith signiﬁcant differential expression identiﬁed by either
method were considered. Of the 17 differentially expressed proteins in
the 2D-PAGE data, 11 were also signiﬁcantly differentially expressed
in the iTRAQ data, and only a single protein (Tpt1) showed a signiﬁcant
conﬂicting directionality between the data types. Of note, this plot high-
lights the ability of 2D-PAGE to separate protein species. For example,
only one out of three detected Ctsd species was signiﬁcantly increasedin the 2D-PAGE data. Finally, we compared the iTRAQ fold-change dis-
tributions and found a clear right shift (toward higher fold-changes)
of the upregulated proteins detected by 2D-PAGE, with Ctsd and
Fabp5 among the most highly upregulated proteins upon 3R4F expo-
sure in the iTRAQ data (Fig. 3D).
In summary, while under these conditions 2D-PAGE demonstrated
less sensitivity than iTRAQ, the results were consistent overall and the
2D-PAGE results conﬁrmed the response proﬁles previously reported
from the iTRAQ (and transcriptomics) data [8, 11].
3.4. Functional network embedding for augmented data interpretation
The low number of identiﬁed and differentially abundant proteins in
the 2D-PAGE data created challenges for biological interpretation be-
yond the level of individual proteins. Therefore, we leveraged a
Fig. 3. Comparison of proteome response proﬁles measured by 2D-PAGE and iTRAQ. (A) Comparison of the number of identiﬁed, quantiﬁed, and differentially expressed proteins
measured by 2D-PAGE and iTRAQ. From top to bottom, the bar chart shows for each exposure group vs. sham comparison: the number of identiﬁed and reliably quantiﬁed proteins
from iTRAQ (see Methods), the number of differentially expressed proteins identiﬁed by iTRAQ (fdr-adj. p-value b 0.05), the number of quantiﬁed protein spots from 2D-PAGE, the
number of differentially expressed protein spots from 2D-PAGE, and the number of differentially expressed protein spots to which a protein identiﬁer could be assigned. (B)
Comparison of 2D-PAGE with iTRAQ differential expression results. Protein sets are deﬁned based on the differentially expressed proteins from the 2D-PAGE analysis (3R4F 5 months
upregulated, 3R4F 7 months up/downregulated). Gene/protein set analysis (GSA) of these sets was performed for each comparison of the iTRAQ data and the mean fold-change, scaled
per gene set, was color coded (ES, enrichment score) and the statistical signiﬁcance indicated (* = fdr-adjusted p-value b0.05). (C) Scatter plot comparing the fold-change responses
of differentially expressed proteins from the 3R4F 7 months vs. sham comparison from 2D-PAGE and iTRAQ data. The color of the protein label indicates whether differential
expression was identiﬁed by 2D-PAGE (green), iTRAQ (blue), or both (red). (D) Empirical cumulative density functions for all quantiﬁed proteins by iTRAQ for the 3R4F 7 months vs.
sham comparison (black), for the proteins with signiﬁcant upregulation by 2D-PAGE (red), and for proteins with signiﬁcant downregulation by 2D-PAGE (blue).
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PAGE and iTRAQ results (Fig. 4). The guiding idea was to embed the dif-
ferentially expressed proteins identiﬁed by 2D-PAGE in larger function-
al clusters co-deﬁned by the 2D-PAGE and iTRAQ results and then
interpret the roles of the differentially expressed proteins (DEPs) iden-
tiﬁed in the 2D-PAGE data in this context. Importantly, if core compo-
nents of these clusters are identiﬁed by both methods, this supports
the biological relevance of these functional clusters. Again, we focused
on the 7-month 3R4F vs. sham exposure comparison, which showed
the largest number of differentially expressed proteins in the 2D-PAGE
data; in particular, we focused on the group of 14 proteins upregulated
upon 3R4F exposure.
In total, seven of the identiﬁed functional clusters contained dif-
ferentially upregulated proteins in the 2D-PAGE data (Fig. 4, num-
bered clusters). Two clusters (12 and 13) were associated with the
immune response (myeloid-associated proteins) and cluster 11 indi-
cates an increase in surfactant metabolism—both effects have been
described previously for this study and have been linked to an
increase in immune cells and surfactant lipids, respectively [8,11].
Especially for clusters 11 and 12, the overall response is well sup-
ported by key nodes in these cluster networks that were measured
by both iTRAQ and 2D-PAGE (Sftpa1 and Ctsd/Ctsc/Asah1). The 2D-
PAGE data also supported the upregulation of an actin cytoskele-
ton-related cluster (3, through Capg/Actb/Arhgdia/Capzb/Efhd2)
and a proteasome cluster (4, Psmd9).
All in all, by embedding the 2D-PAGE-deﬁned DEPs in extended
functional clusters, wewere able to deﬁne the biological responses cap-
tured by 2D-PAGE, especially of immune-, surfactant-, actin cytoskele-
ton-, and proteasome-related processes that are induced by 3R4F CS
exposure.3.5. Measurement of key cluster nodes by reverse-phase protein array
(RPPA)
Having further demonstrated that CS exposure affects speciﬁc func-
tional protein clusters in mouse lung, we set up reverse-phase assays to
target key components of these clusters (Fig. 5) to verify the detected
response from 2D-PAGE and iTRAQ. Overall, the RPPA results were in
agreement with the 2D-PAGE and iTRAQ results, i.e., they showed sig-
niﬁcant increases for the 3R4F exposure groups and limited effects
upon pMRTP exposure and in the later samples from the cessation and
switching groups.4. Discussion
Systems toxicology complements the classical endpoints in toxico-
logical studies by including more extensive measurements of the mo-
lecular effects caused by toxicant exposure [10]. The goal is to globally
analyze the inducedmolecular changes in the context of their biological
networks to derive deeper mechanistic insights for a given
toxicant—toward more robust and more sensitive detection of toxicant
effects and, eventually, to facilitate translation between different assess-
ment systems and species. In addition, by supporting the (mechanism-
based) translation between in vitro and in vivo systems and by provid-
ing more extensive insights from each animal for in vivo studies, sys-
tems toxicology approaches can be effective under the 3Rs principle,
to reﬁne, reduce, and eventually replace animal studies [26].
Toxicants have broad biological effects, for example, the measure-
ment of their effects on the transcriptome, proteome, metabolome,
and lipidome have contributed to the elucidation of toxicological effects
Fig. 4. Functional network embedding for interpretation of the detected exposure response (3R4F 7 months vs. sham). Functional association clusters were identiﬁed for the signiﬁcantly
upregulated proteins in the 2D-PAGE and iTRAQ data (3R4F 7 months vs. sham) (see whole network ﬁgure). Functional protein clusters are color-coded and clusters with differentially
expressed proteins identiﬁed by 2D-PAGE are labeled. For each of these clusters, the association graph is shown and enriched biological functions are indicated.
243A. Elamin et al. / Journal of Proteomics 145 (2016) 237–245and mechanisms [11,12,27–32]. Quantitative proteomics is an impor-
tant component of our systems toxicology assessment strategy, as it
quantitatively captures a broad range of disease-relevant effects of cig-
arette smoke exposure including the xenobiotic, oxidative stress, meta-
bolic and inﬂammatory responses of lung tissue [8,11,12].
Several alternative technologies for the separation, identiﬁcation
and quantiﬁcation of proteome alterations are available, each with
their particular strengths and limitations. Bottom-up proteomics ap-
proaches that combine LC for peptide separation with tandem MS for
identiﬁcation and quantiﬁcation (LC-MS/MS) are becoming increasingly
popular because of improvements in instrumentation and quantiﬁca-
tion approaches [11,33,34]. Gel-based proteomics methods, especiallyFig. 5. Reverse-phase protein array (RPPA) results for selected core cluster components. RPPA re
two technical replicates are included and labeled correspondingly. The fold-change in each expo
key) and statistically signiﬁcant differences are marked (* = fdr-adj. p-value b 0.05). Statistics
values per group are considered.2D-gel based approaches, have been a robust “workhorse” for
toxicoproteomics and are still in common use in toxicological investiga-
tions [12]. 2D-gel workﬂows have been compared with LC-MS/MS
workﬂows previously. For example, Putz et al. compared results from
a 2D-PAGE workﬂow and two LC-MS/MS-based workﬂows, using
iTRAQ- or SILAC-based quantiﬁcation, in a cell culture model of malig-
nant transformation [16]. In these experiments, the iTRAQworkﬂow re-
sulted in more identiﬁed differentially expressed proteins as compared
to 2D-PAGE. Overall, the authors concluded that, while the methods
provide complementary results, iTRAQ outperforms 2D-PAGE both in
the number of identiﬁed proteins and mass-spectrometry analysis
time. However, other authors have pointed out the special merits ofsult heatmapwith target proteins in rows and exposure comparisons in columns. Results of
sure group comparedwith the shamgroup at the same time point is color-coded (see color
based on t-test of log-transformed data; only comparisons with at least three not missing
244 A. Elamin et al. / Journal of Proteomics 145 (2016) 237–2452D-PAGE approaches, especially as a top-down method to study effects
on intact proteins [14].
In the present manuscript, we wanted to address the question of
whether 2D-PAGE could complement LC-MS/MS-based proteomics
within our systems toxicology assessment framework. To this end, we
analyzed lung proteome alterations in a 7-month mouse CS inhalation
study by both 2D-PAGE and an iTRAQ-based LC-MS/MSworkﬂow. As al-
ready reported, the iTRAQ workﬂow was able to capture the extensive
effects of cigarette smoke exposure on the lung, including the xenobiot-
ic, oxidative stress, metabolic, and inﬂammatory responses [8,11]. Pro-
teome proﬁling by 2D-PAGE reproduced the general response,
especially the decreased effect of pMRTP aerosol compared with ciga-
rette smoke exposure and the lack of response in the cessation and
switching samples (Fig. 2) (see limitations below). While the number
of identiﬁed differentially abundant proteins was much lower in the
2D-PAGE analysis than that determined by iTRAQ, the response to ciga-
rette smoke exposure detected by both proteomics methods clearly o-
verlapped (Fig. 3). In summary, we can draw similar conclusions as in
previous studies [16]: 2D-PAGE has a lower sensitivity for the detection
of differentially abundant proteins as compared to iTRAQ, but it is com-
plementary by conﬁrming (and partially extending) the iTRAQ results.
Given the difference in the numbers of differentially abundant pro-
teins identiﬁed by 2D-PAGE and iTRAQ, the question arose of how to
best leverage both data types to support biological interpretation. For
this, we employed a functional network embedding approach, in
which the 2D-PAGE results were included in the observed effects on
functional clusters that were deﬁnedmostly based on the iTRAQ results
(Fig. 4). By this approach, the 2D-PAGE results further supported an in-
duction by cigarette smoke exposure of immune (myeloid)-, surfactant-
, proteasome-, and actin cytoskeleton-related processes. The biological
relevance of the induced immune response and surfactants has been al-
ready discussed based on the iTRAQ data [8, 11], but the effects on the
proteasome and actin cytoskeleton only became clearly apparent in
this integrated analysis.
The proteasome cluster consisted of several proteasome compo-
nents detected as upregulated upon CS exposure in the iTRAQ analysis
and supported by the upregulated Psmd9 component in the 2D-PAGE
analysis. One possibility is that this observation is related to the induced
immune response upon CS exposure, because the proteasome plays an
important role in antigen processing, e.g., by macrophages [35]. Of
note, the proteasome cluster included Psmb10 (Mecl-1), a component
of the immuno-proteasome. Alternatively or in addition, the upregula-
tion of proteasome components could also play a more direct role, e.g.,
by supporting the degradation of proteins damaged upon CS exposure.
For example, the stress response regulator Nrf2 has been implicated in
the regulation of proteasome components upon CS exposure [36]. Func-
tionally, it has been found that interferencewith the proteasome system
increases emphysema susceptibility in mice [37]. Interestingly, upon
acute/short-term exposure, CS impairs proteasome function [38,39],
which might trigger a compensatory increase in the expression of pro-
teasome components under chronic exposure conditions. Overall, sev-
eral links between CS exposure and the proteasome have been
established and we agree with Meiners et al. that it will be pertinent
to further investigate the role of the proteasome and its regulation in
lung diseases and long-term and sustained adaptation to chronic chal-
lenges, e.g., from CS exposure [40].
The integrated analysis of the effects of CS exposure by 2D-PAGE and
iTRAQ also clearly implicated upregulation of actin cytoskeleton compo-
nents in the response of lung tissue (Fig. 4). For example, upregulation
of Capg (actinﬁlament cappingprotein) and Efhd2 (a cytoskeletal adap-
tor protein) was supported by both methods, and 2D-PAGE
complemented the iTRAQ results by providing evidence for the upregu-
lation of Actb (beta actin), Capzb (actin ﬁlament capping protein) and
Arhgdia (rho GDP dissociation inhibitor) upon CS exposure. Similar to
the induction of proteasome components, the upregulation of these cy-
toskeleton components could reﬂect the CS-triggered immune-response, which is associated with a higher motility state of activated
immune cells (e.g., [41]). However, several studies also reported more
speciﬁc effects of CS on the actin cytoskeleton. For example, CSmodulat-
ed the actin cytoskeleton of an airway epithelium cell line [42], cigarette
smoke condensate induced reorganization of the actin cytoskeleton in
human bronchial epithelial cells [43], and treatment of human endothe-
lial cells with cigarette smoke extract resulted in the reorganization of
the actin cytoskeleton [44], and such alterations have been implicated
in the maintenance of epithelial and endothelial barrier functions to
counteract inﬂammatory processes in CS-exposed lungs [45]. The effect
observed here on the actin cytoskeleton likely reﬂects relevant short-
and/or long-term adaptive changes in response to CS exposure in the
lung tissue, which will be interesting to investigate in more cellular
and molecular detail in the future.
4.1. Scope and limitations of this study
The current article was focused on the question of what additional
information the 2D-PAGE approach can add for the analysis of proteome
alterations in the context of a systems toxicology study. The reader is re-
ferred to the publications by Phillips et al. [8] and Titz et al. [11] for a
broader discussion of the biological/toxicological conclusions, especially
for the comparison of CS and pMRTP exposure and cessation/switching
across all measured endpoints. Here, − in addition to the general re-
sponse patterns between the groups – we especially focused on the
last time point of CS exposure, which showed the highest number of dif-
ferentially abundant proteins for the 2D-PAGE approach. Due to its
higher variability compared to the iTRAQ approach (Supplementary
Fig. 1), the 2D-PAGE approach would especially beneﬁt from a larger
number of replicates in future studies. In addition, the number of iden-
tiﬁed proteins could be increased by analyzing the samples on large for-
mat gels (18 cm and 24 cm) and by performing LC separation of the
tryptic peptides. Further study of the effects of different switching/ces-
sation timepoints and of the overall length of the study could yield ad-
ditional insights. For example, for the 2-month switching/cessation
time point, which was chosen based on a previous inhalation study
[17], the majority of 3R4F-related changes became signiﬁcantly attenu-
ated within 3 months of cessation or switching and some of the end
points were as low as the sham at months 5 and 7 [8,11]. In future stud-
ies, inclusion of later switching/cessation time points might reveal
markers both of the reversible, adaptive response as well as of perma-
nent tissue damage.
4.2. Conclusions
Within our systems toxicology framework, we have analyzed the ef-
fects of cigarette smoke and pMRTP aerosol exposure on themouse lung
proteome both by 2D-PAGE and using an iTRAQ workﬂow. Consistent
with previous comparisons (e.g., [16]), the iTRAQworkﬂow clearly pro-
vided greater coverage of the CS-induced effects. Nevertheless, the 2D-
PAGE/MALDI MS/MS results proved usefulness to support the overall
trends, especially the lower effect of pMRTP aerosol than CS on the
lung proteome, and the CS effect on speciﬁc functional categories such
as actin cytoskeleton regulation. While the ﬁeld of toxicoproteomics is
employing more and more gel-free methods (labeled and label-free),
robust 2D-PAGE retains a role as a complementary method for intact
proteins.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jprot.2016.05.037.
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